Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials - Wikidata - awgldk - TriplyDB

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

http://www.wikidata.org/entity/Q26829540

about

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack Unresolved or Contradictory Issues About Management of Patients With Patent Foramen Ovale and Previous Cryptogenic Stroke: Additional Randomized Controlled Trials Are Eagerly Awaited Prevention of recurrent stroke in patients with patent foramen ovale Transcatheter closure of PFO as secondary prevention of cryptogenic stroke.Percutaneous closure versus medical therapy alone for cryptogenic stroke patients with a patent foramen ovale: meta-analysis of randomized controlled trials.Right-to-left shunt detection using contrast-enhanced transcranial Doppler: A comparison of provocation maneuvers between coughing and a modified Valsalva maneuver.A time-series study of percutaneous closure of patent foramen ovale: premature adoption?Current status of percutaneous PFO closure.Accuracy of conventional transthoracic echocardiography for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies.Two-dimensional echocardiography using second harmonic imaging for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies.Causes of death among persons who survive an acute ischemic stroke.Diagnosis and management of patent foramen ovale.Percutaneous closure of patent foramen ovale: an underutilized prevention?A focus on the prognosis and management of ischemic heart disease in patients without evidence of obstructive coronary artery disease.Cryptogenic Stroke with a Patent Foramen Ovale: Medical Therapy, Percutaneous Intervention, or Surgery.Transcranial Doppler: Does Addition of Blood to Agitated Saline Affect Sensitivity for Detecting Cardiac Right-to-Left Shunt?Patent foramen ovale and cryptogenic stroke: from studies to clinical practice: Position paper of the Italian Chapter, International Society Cardiovascular Ultrasound.Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.Recurrent cerebral ischemia after patent foramen ovale percutaneous closure in older patients: A two-center registry study.Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.Role of occlusive devices to prevent thromboembolism among persons with a patent foramen ovale and prior stroke.Device closure for patent foramen ovale following cryptogenic stroke: a survey of current practice in the UK Paradoxical coronary artery embolism - a rare cause of myocardial infarction.Brain abscess associated with patent foramen ovale.Percutaneous closure of a patent foramen ovale after cryptogenic stroke.Percutaneous closure of patent foramen ovale: safe and effective but underutilized.Echocardiographic findings in simple and complex patent foramen ovale before and after transcatheter closure.Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies.Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.How to Understand Patent Foramen Ovale Clinical Significance - Part II: Therapeutic Strategies in Cryptogenic Stroke Patent foramen ovale and atrial fibrillation as causes of cryptogenic stroke: is treatment with surgery superior to device closure and anticoagulation? A review of the literature Patent foramen ovale

P2860

Q24187286-3F698C3E-6F15-4746-A4A9-FB9913E8E329 Q26747769-11A38262-FB8D-4484-BA40-D482742B8501 Q27007029-7C3A8220-659D-43D9-B5F0-77E008620765 Q30250017-D3FA9025-3CD6-45B7-9080-0B1AC9F99689 Q33996768-5E9578A9-5F10-47BD-8F1B-79C9478A954F Q36338432-9F03A210-F195-4792-BC36-1D11B6A513BB Q36472707-717C7CC7-BC25-413A-BD29-C32053C28741 Q38196338-301C3BFD-5041-4E5D-82B1-5DE3FF626AC9 Q38201121-7CA2E039-3DF6-415D-8F12-9A615ACBAFEE Q38205136-0380B994-88C0-47A5-BFE8-BDE33CDCD095 Q38222122-21D30210-6FB1-4E2F-BC24-5A85A57DF7AA Q38542431-65EE3943-92C6-454B-B4A5-2A67FBC16F33 Q38561876-8BFEEEC7-4F74-4F40-9C25-6C67159F20AD Q38574181-BC39359C-52AC-4F01-9FEC-61D0036305CD Q38703003-13302049-4350-4D75-8165-7002711B65AA Q38812502-01917D3A-2F69-4F90-B93A-AC95009F96BB Q38888064-994DDFA5-9750-4D7B-BE0C-249F29465115 Q39878127-EE34D54B-5816-4544-AE6C-1A6F31C5B9A5 Q40803677-2EFB2D63-B3B7-47B6-AB10-647BFB0963A7 Q40805425-D365706E-2836-4B58-9413-5F6B912F7B8A Q41284381-5E27198E-E4F3-4497-BA40-2840B3CF3223 Q42650183-BCED76D4-DAA7-4D50-8CE0-8ADA787D59CA Q43174654-6B4D826B-5DD6-4766-8BDD-6C4DAE93A4D4 Q48687667-D56CB80D-0C56-4344-A2BC-5EE4F57A08D9 Q49591116-5BC2FE47-9F56-4EBA-ACF0-748A685B43A8 Q53348128-E37EE542-A70E-4B3A-B9B9-9FCF67B6505C Q53469303-BA3BAF39-A333-4194-8662-44743EE47440 Q53599359-47DF083C-BE8F-4800-B907-6AACFE8499B4 Q55505555-529CBB99-AF75-4226-BB88-38256D40CA59 Q57642050-934F8B97-8DA8-4957-A497-315B27FFA281 Q58713349-6F83518E-99AE-444D-8916-8E2B0A5C2CA2 Q59191961-CF518283-529D-4F85-B127-5EBC660DB389

P2860

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

http://www.wikidata.org/entity/Q26829540

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Patent foramen ovale transcath ...... f randomized controlled trials

@ast

Patent foramen ovale transcath ...... f randomized controlled trials

@en

Patent foramen ovale transcath ...... f randomized controlled trials

@nl

type

label

Patent foramen ovale transcath ...... f randomized controlled trials

@ast

Patent foramen ovale transcath ...... f randomized controlled trials

@en

Patent foramen ovale transcath ...... f randomized controlled trials

@nl

prefLabel

Patent foramen ovale transcath ...... f randomized controlled trials

@ast

Patent foramen ovale transcath ...... f randomized controlled trials

@en

Patent foramen ovale transcath ...... f randomized controlled trials

@nl

P1433

Q26829540-636B8C46-3DC5-4E5D-B815-BF223E26E796

P1476

Q26829540-BD55DCDD-1976-4A3B-B6FC-97FC9278E913

P2093

Q26829540-16614791-AB86-4744-A710-778B1B9B6757

Q26829540-49BDDD97-D91B-4F67-8E02-A50D9A4BFC94

Q26829540-59069FB6-F37E-4284-B3E2-A37F5576A634

Q26829540-78D116F1-8202-4CD0-BE89-BD2369B0CA66

Q26829540-7B82F634-4B5A-46DA-9B93-2546896D1785

Q26829540-CF4B946C-C0C7-4E99-9747-678AE4603F80

P2860

Q26829540-0376BC1E-0A07-4417-ABD3-3159CB35E1DA

Q26829540-1B76C288-2ED2-485F-8097-E31FD2240321

Q26829540-2828337C-E04D-4B80-BD7C-5354C409EB0B

Q26829540-3DC80719-3B34-4F0F-A48E-4247495CEB80

Q26829540-472BEF04-25D6-4480-AC05-FB9B4F288C59

Q26829540-7B11D936-6051-4A1E-B82D-78B98D1A0559

Q26829540-8ADAD61E-91B5-4965-BF93-690938A24833

Q26829540-9EB23C69-E561-4A41-9C17-C5FDB9ED4A3D

Q26829540-B9361463-8043-4626-91EC-554C64AC3177

Q26829540-C351358C-9385-4FFC-9403-98A1FD906227

P304

Q26829540-3CBF46CF-BD3E-42D5-A869-CC5431AEA391

P31

Q26829540-20CB07E2-FEF2-4176-8282-A47583D8CE06

Q26829540-4B22167C-67BF-4E0C-96D0-22B945CA317F

Q26829540-D80D7FE6-FC2A-48EF-BB8A-C14EB6E7E840

P356

Q26829540-A7495361-45CF-42F2-AF98-70236AE6D1EE

P407

Q26829540-F56D88E5-6923-422F-91C9-61999A9ED41A

P433

Q26829540-517A2441-285E-4303-BE8C-CB28BAE54FEC

P478

Q26829540-46C1CBE9-D4BC-44A5-B939-378360DF11D9

P577

Q26829540-803EED81-7FB2-45F3-B2BC-108BFB3190E2

P5875

Q26829540-A6792CA2-2BB9-4DE6-8182-7209471E9822

P698

Q26829540-8052EB07-3EFB-4D48-943E-3A430477D3D6

P921

Q26829540-E6D09331-681F-4701-A507-BFD9B5F36259

P356

P1433

European Heart Journal

P1476

Patent foramen ovale transcath ...... f randomized controlled trials

@en

P2093

A. Romero-Corral

http://www.w3.org/2001/XMLSchema#string

C. F. Witzke

http://www.w3.org/2001/XMLSchema#string

D. L. Morris

http://www.w3.org/2001/XMLSchema#string

I. F. Palacios

http://www.w3.org/2001/XMLSchema#string

P. Junpaparp

http://www.w3.org/2001/XMLSchema#string

P. Rengifo-Moreno

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Indications for the closure of patent foramen ovale

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study

Closure or medical therapy for cryptogenic stroke with patent foramen ovale.

Scales to assess the quality of randomized controlled trials: a systematic review.

Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.

Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.

Still no closure on the question of PFO closure.

P304

3342-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1093/EURHEARTJ/EHT285

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

248706084

http://www.w3.org/2001/XMLSchema#string

P698

23847132

http://www.w3.org/2001/XMLSchema#string

P921